Dual incretin (GLP-1 and GIP) modulator
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual incretin (GLP-1 and GIP) modulator, covering 2025-12-26 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions [Phase 4]